.png)
From May 4–7, 2025, as part of the Prague.bio initiative, we participated in the prestigious international Swiss Biotech Day conference in Basel. This event, which welcomed over 3,000 participants from around the globe this year, is one of Europe’s largest platforms for showcasing biotech innovation.
Our company had the honor of presenting Floxgen - an innovative AI-driven genomic data analysis solution-in the national representatives section. We attracted attention from industry experts and received concrete offers for collaboration and distribution. Discussions took place with representatives from France, Canada, Brazil, Sweden, Japan, and Germany.
We are especially grateful for the positive feedback from Swiss companies, who expressed interest in actively supporting the development of Floxgen locally. Two members of the Swiss ecosystem offered to help us connect with pharmaceutical and R&D institutions, which we see as a key step in our international expansion.
Among the conference highlights was NVIDIA’s presentation of cutting-edge AI technology for genomic data processing. As we already collaborate with NVIDIA, we are excited to begin testing and integrating their solutions into the Floxgen platform. This synergy has the potential to significantly accelerate and enhance genetic data analysis.
At the close of the conference, we met with the Czech ambassador to Switzerland, who expressed strong support for the Czech biotech sector and interest in further assisting its international growth. We see this as an important signal for the future development of both our company and the broader Czech ecosystem.
Our participation at Swiss Biotech Day 2025 confirmed the international relevance of our research and development. We are ready to build new partnerships and expand the impact of our technologies worldwide.
